Compounds > pteridines

pteridines and fluorouracil

pteridines has been researched along with fluorouracil in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lorenz, J; Mössner, J; Wiedmann, M; Wolf, S1
Lorenz, J; Mössner, J; Thrum, S; Wiedmann, M1
Dunn, SE; Fotovati, A; Hu, K; Law, JH1

Other Studies

3 other study(ies) available for pteridines and fluorouracil

ArticleYear
Treatment of biliary tract cancer with NVP-AEW541: mechanisms of action and resistance.
    World journal of gastroenterology, 2010, Jan-14, Volume: 16, Issue:2

    Topics: Antineoplastic Agents; Biliary Tract Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Fluorouracil; Gallbladder Neoplasms; Gemcitabine; Humans; Proto-Oncogene Proteins c-akt; Pteridines; Pyrimidines; Pyrroles; Receptor, IGF Type 1

2010
Polo-like kinase 1 inhibition as a new therapeutic modality in therapy of cholangiocarcinoma.
    Anticancer research, 2011, Volume: 31, Issue:10

    Topics: Cell Cycle; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cholangiocarcinoma; Deoxycytidine; Fluorouracil; Gemcitabine; Gene Expression Regulation, Neoplastic; Humans; Polo-Like Kinase 1; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; Pyrimidines; Pyrroles; RNA, Messenger

2011
Small interfering RNA library screen identified polo-like kinase-1 (PLK1) as a potential therapeutic target for breast cancer that uniquely eliminates tumor-initiating cells.
    Breast cancer research : BCR, 2012, Feb-06, Volume: 14, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cyclin B1; Doxorubicin; Female; Fluorouracil; Gene Expression; Gene Knockdown Techniques; Gene Library; Humans; Hyaluronan Receptors; Molecular Targeted Therapy; Neoplastic Stem Cells; Paclitaxel; Polo-Like Kinase 1; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Pteridines; RNA Interference; RNA, Small Interfering

2012